Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy and prostate cancer.

Joseph M Kaminski1, James B Summers, Matthew B Ward

  • 1Department of Radiology, Medical College of Georgia, Augusta, GA 30912, USA.

Cancer Treatment Reviews
|June 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synergistic senolytic-regenerative therapy significantly extends healthspan and lifespan.

Journal of translational medicine·2026
Same author

Biomimetic and personalized nanovaccines in cancer immunotherapy: Design innovations, translational challenges, and future directions.

Journal of advanced research·2026
Same author

Reduction of solid tumors by senescent cell immunization.

Journal of translational medicine·2025
Same author

Development of Allogeneic Stem Cell-Based Platform for Delivery and Potentiation of Oncolytic Virotherapy.

Cancers·2022
Same author

Correction to: Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers.

Journal of translational medicine·2021
Same author

Novel Survivin Peptides Screened With Computer Algorithm Induce Cytotoxic T Lymphocytes With Higher Cytotoxic Efficiency to Cancer Cells.

Frontiers in molecular biosciences·2020

Prostate cancer immunotherapy shows promise but requires more research. Overcoming challenges like vector design and tumor evasion is crucial for effective treatment, especially for metastatic disease.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Therapeutics

Background:

  • Prostate cancer is a leading cause of cancer death in the US.
  • Current therapeutic options are limited, particularly for metastatic prostate cancer.
  • New treatment modalities are actively being investigated.

Purpose of the Study:

  • To explore the potential of immunotherapy as a viable treatment for prostate cancer.
  • To highlight the need for combination approaches in cancer therapy.
  • To identify existing obstacles in prostate cancer immunotherapy.

Main Methods:

  • Review of current therapeutic limitations in prostate cancer.
  • Exploration of novel therapeutic strategies including immunotherapy.
  • Identification of challenges in implementing immunotherapy.

Related Experiment Videos

Main Results:

  • Immunotherapy is a feasible and promising therapeutic modality for prostate cancer.
  • A combination approach is likely necessary for treating most malignancies.
  • Significant obstacles remain in immunotherapy research and application.

Conclusions:

  • Further research in basic immunology is essential for advancing prostate cancer immunotherapy.
  • Addressing challenges such as vector design, tumoricidal specificity, and tumor evasion is critical.
  • Realizing the full therapeutic benefit of immunotherapy requires overcoming these obstacles.